Oral kinase inhibitors, biologics and serious infection in rheumatoid arthritis

被引：0
|
作者：
Bates, Benjamin A. [1 ]
Gilman, Joshua P. [1 ]
Gandhi, Poonam P. [1 ]
Nonnenmacher, Edward [1 ]
Taylor, Matthew [1 ]
Chen, Haoqian [1 ]
Setoguchi, Soko [1 ]
机构：
[1] Rutgers State Univ, New Brunswick, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
994
引用
收藏
页码：482 / 482
页数：1
相关论文
共 50 条
  • [31] Efficacy of Janus kinase inhibitors in rheumatoid arthritis
    Camille Langbour
    Jessica Rene
    Philippe Goupille
    Guillermo Carvajal Alegria
    Inflammation Research, 2023, 72 : 1121 - 1132
  • [32] Efficacy of Janus kinase inhibitors in rheumatoid arthritis
    Langbour, Camille
    Rene, Jessica
    Goupille, Philippe
    Alegria, Guillermo Carvajal
    INFLAMMATION RESEARCH, 2023, 72 (05) : 1121 - 1132
  • [33] COMPARATIVE RISKS FOR SERIOUS INFECTIONS ASSOCIATED WITH BIOLOGICS IN HIGH RISK RHEUMATOID ARTHRITIS PATIENTS
    Yun, H.
    Xie, F.
    Delzell, E.
    Chen, L.
    Levitan, E.
    Lewis, J.
    Saag, K. G.
    Beukelman, T.
    Winthrop, K. L.
    Baddley, J. W.
    Muntner, P.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 553 - 554
  • [34] Treatment of rheumatoid arthritis with biologics
    Panayi, GS
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 : S22 - S23
  • [35] Biologics for Early Rheumatoid Arthritis
    Krueger, K.
    AKTUELLE RHEUMATOLOGIE, 2013, 38 (01) : 25 - 29
  • [36] Biologics in early rheumatoid arthritis
    de Vries-Bouwstra, JK
    Dijkmans, BAC
    Breedveld, FC
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (04) : 745 - +
  • [37] New biologics for rheumatoid arthritis
    Choy, E.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2011, 41 (03): : 234 - 237
  • [38] Risk of Serious Infection and Malignancy in Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Biologics
    Thyagarajan, Veena
    Norman, Heather
    Enger, Cheryl
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 160 - 160
  • [39] The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database
    Ryoko Sakai
    Soo-Kyung Cho
    Toshihiro Nanki
    Ryuji Koike
    Kaori Watanabe
    Hayato Yamazaki
    Hayato Nagasawa
    Koichi Amano
    Yoshiya Tanaka
    Takayuki Sumida
    Atsushi Ihata
    Shinsuke Yasuda
    Atsuo Nakajima
    Takahiko Sugihara
    Naoto Tamura
    Takao Fujii
    Hiroaki Dobashi
    Yasushi Miura
    Nobuyuki Miyasaka
    Masayoshi Harigai
    Rheumatology International, 2014, 34 : 1729 - 1736
  • [40] The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database
    Sakai, Ryoko
    Cho, Soo-Kyung
    Nanki, Toshihiro
    Koike, Ryuji
    Watanabe, Kaori
    Yamazaki, Hayato
    Nagasawa, Hayato
    Amano, Koichi
    Tanaka, Yoshiya
    Sumida, Takayuki
    Ihata, Atsushi
    Yasuda, Shinsuke
    Nakajima, Atsuo
    Sugihara, Takahiko
    Tamura, Naoto
    Fujii, Takao
    Dobashi, Hiroaki
    Miura, Yasushi
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (12) : 1729 - 1736
12345